Bausch Health Cos Price to Sales Ratio 2010-2024 | BHC

Historical PS ratio values for Bausch Health Cos (BHC) over the last 10 years. The current P/S ratio for Bausch Health Cos as of November 20, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bausch Health Cos P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-11-20 8.19 0.31
2024-09-30 8.16 $26.03 0.31
2024-06-30 6.97 $25.12 0.28
2023-12-31 8.02 $23.98 0.33
2023-09-30 8.22 $23.44 0.35
2023-06-30 8.00 $23.18 0.35
2023-03-31 8.10 $22.91 0.35
2022-12-31 6.28 $22.99 0.27
2024-03-31 10.61 $22.25 0.48
2022-09-30 6.89 $22.50 0.31
2022-06-30 8.36 $22.66 0.37
2022-03-31 22.85 $23.08 0.99
2021-12-31 27.61 $23.45 1.18
2021-09-30 27.85 $23.56 1.18
2021-06-30 29.32 $23.74 1.24
2021-03-31 31.74 $22.57 1.41
2020-12-31 20.80 $22.59 0.92
2020-09-30 15.54 $22.67 0.69
2020-06-30 18.29 $22.96 0.80
2020-03-31 15.50 $24.39 0.64
2019-12-31 29.92 $24.44 1.22
2019-09-30 21.85 $24.16 0.90
2019-06-30 25.22 $23.96 1.05
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00